Skip to content

Psychedelic-assisted therapy: all studies

Page 283 of 294: studies 2,821 to 2,830 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

The Evolution of Psychology

Psychology and Cognitive Sciences - Open Journal December 7, 2015 Sharon Joy Ng 3 citations

Today the discipline of psychology is branching out to embrace research into more esoteric areas that can provide the means and techniques that will empower people to assume greater self-responsibility for their mental and physical health while simultaneously empowering each person with powerful tools for health and well-being. I refer to the increased interest and research in the contemplative...

LSD enhances the emotional response to music.

Psychopharmacology October 2015 Mendel Kaelen, Frederick S. Barrett, Leor Roseman et al.

There is renewed interest in the therapeutic potential of psychedelic drugs such as lysergic acid diethylamide (LSD). LSD was used extensively in the 1950s and 1960s as an adjunct in psychotherapy, reportedly enhancing emotionality. Music is an effective tool to evoke and study emotion and is considered an important element in psychedelic-assisted psychotherapy; however, the hypothesis that...

[Psilocybin - public available psychodysleptic].

September 7, 2015 Karolina Dydak, Mariola Śliwińska‐mossoń, Halina Milnerowicz 5 citations

Substances of plant origin have been used to induce hallucinations for a long time, in religious ceremonies and rituals as well as in pain relief. Psilocybin and psilocin naturally occur in the fungal genus Psilocybe. Due to the psychedelic effects and relative harmlessness of these substances and the fact that they do not cause physical addiction, psilocybin and psilocin recently have been...

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities

Frontiers in Immunology July 14, 2015 Attila Szabo 153 citations

Classical psychedelics are psychoactive substances, which, besides their psychopharmacological activity, have also been shown to exert significant modulatory effects on immune responses by altering signaling pathways involved in inflammation, cellular proliferation, and cell survival via activating NF-κB and mitogen-activated protein kinases. Recently, several neurotransmitter receptors...

DOI: 10.3389/fimmu.2015.00358 (opens in new tab) Cognitive science Data science

Therapeutic potential of psychedelic agents

The British Journal of Psychiatry May 1, 2015 Matthew M. Nour, Jacob Krzanowski 2 citations

Therapeutic potential of psychedelic agentsAmphetamine, methylphenidate, morphine, heroin and ketamine are all drugs that can potentially be used clinically but, whenever we hear the word MDMA, the first thoughts that come to mind are of ecstasy, rave parties and people behaving in an odd manner and experiencing hallucinations, paranoia and disinhibition.Recently, there has been a lot of...

Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary

Drug Science, Policy and Law March 24, 2015 Ben Sessa, Friederike Meckel Fischer 39 citations

Underground psychedelic-assisted psychotherapy has persisted in Europe despite the banning of the substances LSD and MDMA in the 1960s and 1980s, respectively. This article describes the work of a Zurich-based psychotherapist providing individual and group psycholytic psychotherapy, whose practice persisted for several years before she was arrested in 2009. The article provides commentary on...

DOI: 10.1177/2050324515578080 (opens in new tab) MDMA Psychotherapist Mainstream Context archaeology +2

Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction

Current Drug Abuse Reviews January 9, 2015 Albert Garcia‐romeu, Roland R. Griffiths, Matthew W. Johnson 480 citations

Psilocybin-occasioned mystical experiences have been linked to persisting effects in healthy volunteers including positive changes in behavior, attitudes, and values, and increases in the personality domain of openness. In an open-label pilot-study of psilocybin-facilitated smoking addiction treatment, 15 smokers received 2 or 3 doses of psilocybin in the context of cognitive behavioral therapy...

The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder.

Journal of Psychoactive Drugs 2015 Timothy Amoroso

Prior to 1985, ±3,4-methylenedioxymethamphetamine (MDMA) was readily used as a psychotherapeutic adjunct. As MDMA became popular in treating various psychiatric illnesses by mental health professionals, the public started to abuse the MDMA-containing recreational drug "ecstasy." This alarmed the DEA, which led to emergency scheduling of MDMA as a Schedule I drug. Due to its scheduling in 1985,...

DOI: 10.1080/02791072.2015.1094156 (opens in new tab) Full text (opens in new tab) PTSD MDMA-Assisted Psychotherapy Posttraumatic stress disorder

From experimental psychosis to resolving traumatic pasts

Cahiers du monde russe 2015 S. Marks 17 citations

Drawing on research papers, archives and scientific memoirs, this paper reconstructs the psychedelic research projects developed in Prague between 1954 and1974, situating psychiatric research in Communist Czechoslovakia within the transnational context of Cold War science. It traces attempts to induce experimental psychosis as a means of exploring the aetiology of schizophrenia; as well as the...

Can psychedelic compounds play a part in drug dependence therapy?

The British Journal of Psychiatry 2015 Ben Sessa, Matthew W. Johnson 58 citations

Summary After a 40-year hiatus there is now a revisiting of psychedelic drug therapy throughout psychiatry, with studies examining the drugs psilocybin, ketamine, ibogaine and ayahuasca in the treatment of drug dependence. Limitations to these therapies are both clinical and legal, but the possibility of improving outcomes for patients with substance dependency imposes an obligation to research...